• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同亚型的 HIV-1 再次感染并不会增强针对自身病毒的中和抗体反应。

Superinfection by discordant subtypes of HIV-1 does not enhance the neutralizing antibody response against autologous virus.

机构信息

Department of Pathology, New York University School of Medicine, New York, New York, United States of America.

出版信息

PLoS One. 2012;7(6):e38989. doi: 10.1371/journal.pone.0038989. Epub 2012 Jun 14.

DOI:10.1371/journal.pone.0038989
PMID:22720009
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3375243/
Abstract

Recent studies have demonstrated that both the potency and breadth of the humoral anti-HIV-1 immune response in generating neutralizing antibodies (nAbs) against heterologous viruses are significantly enhanced after superinfection by discordant HIV-1 subtypes, suggesting that repeated exposure of the immune system to highly diverse HIV-1 antigens can significantly improve anti-HIV-1 immunity. Thus, we investigated whether sequential plasma from these subjects superinfected with discordant HIV-1 subtypes, who exhibit broad nAbs against heterologous viruses, also neutralize their discordant early autologous viruses with increasing potency. Comparing the neutralization capacities of sequential plasma obtained before and after superinfection of 4 subjects to those of matched plasma obtained from 4 singly infected control subjects, no difference in the increase in neutralization capacity was observed between the two groups (p = 0.328). Overall, a higher increase in neutralization over time was detected in the singly infected patients (mean change in IC(50) titer from first to last plasma sample: 183.4) compared to the superinfected study subjects (mean change in IC(50) titer from first to last plasma sample: 66.5). Analysis of the Breadth-Potency Scores confirmed that there was no significant difference in the increase in superinfected and singly infected study subjects (p = 0.234). These studies suggest that while superinfection by discordant subtypes induces antibodies with enhanced neutralizing breadth and potency against heterologous viruses, the potency to neutralize their autologous viruses is not better than those seen in singly infected patients.

摘要

最近的研究表明,在被不同亚型的 HIV-1 再次感染后,体液抗 HIV-1 免疫反应产生中和抗体(nAbs)的效力和广度都会显著增强,这表明免疫系统反复接触高度多样化的 HIV-1 抗原可以显著改善抗 HIV-1 免疫。因此,我们研究了这些被不同亚型 HIV-1 再次感染的个体的序贯血浆,这些个体对异源病毒表现出广泛的 nAbs,是否也能以递增的效力中和其异源的早期自体病毒。比较 4 名被不同亚型 HIV-1 再次感染的个体的序贯血浆与 4 名单一感染对照个体的匹配血浆的中和能力,我们没有观察到两组之间中和能力增加的差异(p=0.328)。总体而言,在单一感染患者中,随着时间的推移,中和能力的增加更高(从第一份到最后一份血浆样本的 IC50 滴度变化:183.4),而在再次感染的研究对象中,中和能力的增加较低(从第一份到最后一份血浆样本的 IC50 滴度变化:66.5)。广度-效力评分分析证实,再次感染和单一感染研究对象的增加没有显著差异(p=0.234)。这些研究表明,虽然不同亚型的再次感染会诱导产生针对异源病毒具有增强中和广度和效力的抗体,但对其自体病毒的中和效力并不优于单一感染患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44a2/3375243/3734ff18b1d6/pone.0038989.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44a2/3375243/eb5c52ea4328/pone.0038989.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44a2/3375243/639a863d5b9c/pone.0038989.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44a2/3375243/c70620867171/pone.0038989.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44a2/3375243/8b5a7798aab2/pone.0038989.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44a2/3375243/1bb71b4c01cf/pone.0038989.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44a2/3375243/b6d33f447713/pone.0038989.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44a2/3375243/4ef9f5eff146/pone.0038989.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44a2/3375243/3734ff18b1d6/pone.0038989.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44a2/3375243/eb5c52ea4328/pone.0038989.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44a2/3375243/639a863d5b9c/pone.0038989.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44a2/3375243/c70620867171/pone.0038989.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44a2/3375243/8b5a7798aab2/pone.0038989.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44a2/3375243/1bb71b4c01cf/pone.0038989.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44a2/3375243/b6d33f447713/pone.0038989.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44a2/3375243/4ef9f5eff146/pone.0038989.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44a2/3375243/3734ff18b1d6/pone.0038989.g008.jpg

相似文献

1
Superinfection by discordant subtypes of HIV-1 does not enhance the neutralizing antibody response against autologous virus.不同亚型的 HIV-1 再次感染并不会增强针对自身病毒的中和抗体反应。
PLoS One. 2012;7(6):e38989. doi: 10.1371/journal.pone.0038989. Epub 2012 Jun 14.
2
HIV-1 superinfection in women broadens and strengthens the neutralizing antibody response.HIV-1 超级感染拓宽并增强了女性体内的中和抗体反应。
PLoS Pathog. 2012;8(3):e1002611. doi: 10.1371/journal.ppat.1002611. Epub 2012 Mar 29.
3
HIV-1 subtype C superinfected individuals mount low autologous neutralizing antibody responses prior to intrasubtype superinfection.HIV-1 亚型 C 超级感染个体在同种亚型内再次感染之前会产生低水平的自体中和抗体反应。
Retrovirology. 2012 Sep 20;9:76. doi: 10.1186/1742-4690-9-76.
4
HIV-1 superinfection can occur in the presence of broadly neutralizing antibodies.HIV-1 超级感染可在存在广泛中和抗体的情况下发生。
Vaccine. 2018 Jan 25;36(4):578-586. doi: 10.1016/j.vaccine.2017.11.075. Epub 2017 Dec 20.
5
Infection by discordant strains of HIV-1 markedly enhances the neutralizing antibody response against heterologous virus.不同 HIV-1 株系的感染显著增强了针对异源病毒的中和抗体反应。
J Virol. 2010 Sep;84(18):9415-26. doi: 10.1128/JVI.02732-09. Epub 2010 Jul 14.
6
Intrasubtype B HIV-1 Superinfection Correlates with Delayed Neutralizing Antibody Response.B亚型人免疫缺陷病毒1型(HIV-1)的亚型内超感染与中和抗体反应延迟相关。
J Virol. 2017 Aug 10;91(17). doi: 10.1128/JVI.00475-17. Print 2017 Sep 1.
7
Maternal but Not Infant Anti-HIV-1 Neutralizing Antibody Response Associates with Enhanced Transmission and Infant Morbidity.母婴抗 HIV-1 中和抗体反应与增强的传播和婴儿发病相关。
mBio. 2017 Oct 24;8(5):e01373-17. doi: 10.1128/mBio.01373-17.
8
Human immunodeficiency virus type 1 superinfection occurs despite relatively robust neutralizing antibody responses.尽管存在相对较强的中和抗体反应,但仍会发生1型人类免疫缺陷病毒的重复感染。
J Virol. 2008 Dec;82(24):12094-103. doi: 10.1128/JVI.01730-08. Epub 2008 Oct 8.
9
The Neutralizing Antibody Response in an Individual with Triple HIV-1 Infection Remains Directed at the First Infecting Subtype.一名三重感染HIV-1的个体中的中和抗体反应仍针对首次感染的亚型。
AIDS Res Hum Retroviruses. 2016 Oct/Nov;32(10-11):1135-1142. doi: 10.1089/aid.2015.0324. Epub 2016 Feb 24.
10
Profiles of neutralizing antibody response in chronically human immunodeficiency virus type 1 clade B'-infected former plasma donors from China naive to antiretroviral therapy.中国慢性 HIV-1 型 B′组感染且未接受过抗病毒治疗的前血浆供者的中和抗体反应特征。
J Gen Virol. 2012 Oct;93(Pt 10):2267-2278. doi: 10.1099/vir.0.043802-0. Epub 2012 Jul 12.

引用本文的文献

1
Development of a Versatile, Near Full Genome Amplification and Sequencing Approach for a Broad Variety of HIV-1 Group M Variants.开发一种通用的、近乎完整基因组扩增和测序方法,用于广泛的 HIV-1 M 组变体。
Viruses. 2019 Apr 1;11(4):317. doi: 10.3390/v11040317.
2
Contrasting antibody responses to intrasubtype superinfection with CRF02_AG.与CRF02_AG亚型内重复感染形成对比的抗体反应。
PLoS One. 2017 Mar 13;12(3):e0173705. doi: 10.1371/journal.pone.0173705. eCollection 2017.
3
Repressive effect of primary virus replication on superinfection correlated with gut-derived central memory CD4(+) T cells in SHIV-infected Chinese rhesus macaques.

本文引用的文献

1
HIV-1 superinfection in women broadens and strengthens the neutralizing antibody response.HIV-1 超级感染拓宽并增强了女性体内的中和抗体反应。
PLoS Pathog. 2012;8(3):e1002611. doi: 10.1371/journal.ppat.1002611. Epub 2012 Mar 29.
2
The Antibody Response against HIV-1.HIV-1 的抗体反应。
Cold Spring Harb Perspect Med. 2012 Jan;2(1):a007039. doi: 10.1101/cshperspect.a007039.
3
Cross-clade HIV-1 neutralizing antibodies induced with V3-scaffold protein immunogens following priming with gp120 DNA.V3 支架蛋白免疫原诱导的跨 HIV-1 中和抗体,继 gp120 DNA 初免之后。
原发病毒复制对再感染的抑制作用与 SHIV 感染的中国恒河猴肠道来源的中枢记忆性 CD4(+) T 细胞相关。
PLoS One. 2013 Sep 2;8(9):e72295. doi: 10.1371/journal.pone.0072295. eCollection 2013.
4
Multiple pathways of escape from HIV broadly cross-neutralizing V2-dependent antibodies.多种逃逸 HIV 广谱中和 V2 依赖型抗体的途径。
J Virol. 2013 May;87(9):4882-94. doi: 10.1128/JVI.03424-12. Epub 2013 Feb 13.
J Virol. 2011 Oct;85(19):9887-98. doi: 10.1128/JVI.05086-11. Epub 2011 Jul 27.
4
Infection by discordant strains of HIV-1 markedly enhances the neutralizing antibody response against heterologous virus.不同 HIV-1 株系的感染显著增强了针对异源病毒的中和抗体反应。
J Virol. 2010 Sep;84(18):9415-26. doi: 10.1128/JVI.02732-09. Epub 2010 Jul 14.
5
Longitudinal quasispecies analysis of viral variants in HIV type 1 dually infected individuals highlights the importance of sequence identity in viral recombination.1型人类免疫缺陷病毒双重感染个体中病毒变体的纵向准种分析突出了序列同一性在病毒重组中的重要性。
AIDS Res Hum Retroviruses. 2010 Mar;26(3):253-64. doi: 10.1089/aid.2009.0174.
6
The role of antibodies in HIV vaccines.抗体在 HIV 疫苗中的作用。
Annu Rev Immunol. 2010;28:413-44. doi: 10.1146/annurev-immunol-030409-101256.
7
Broadly neutralizing monoclonal antibodies 2F5 and 4E10 directed against the human immunodeficiency virus type 1 gp41 membrane-proximal external region protect against mucosal challenge by simian-human immunodeficiency virus SHIVBa-L.广谱中和单克隆抗体 2F5 和 4E10 针对人类免疫缺陷病毒 1 型 gp41 膜近端外部区域,可预防猴免疫缺陷病毒 SHIVBa-L 的粘膜攻击。
J Virol. 2010 Feb;84(3):1302-13. doi: 10.1128/JVI.01272-09. Epub 2009 Nov 11.
8
Antibody specificities associated with neutralization breadth in plasma from human immunodeficiency virus type 1 subtype C-infected blood donors.与1型人类免疫缺陷病毒C亚型感染献血者血浆中和广度相关的抗体特异性
J Virol. 2009 Sep;83(17):8925-37. doi: 10.1128/JVI.00758-09. Epub 2009 Jun 24.
9
Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques.低滴度抗体对猕猴低剂量重复黏膜SHIV攻击具有有效的保护作用。
Nat Med. 2009 Aug;15(8):951-4. doi: 10.1038/nm.1974. Epub 2009 Jun 7.
10
High frequency of HIV-1 dual infections among HIV-positive individuals in Cameroon, West Central Africa.在中西非喀麦隆的艾滋病毒阳性个体中,艾滋病毒-1双重感染的高发生率。
J Acquir Immune Defic Syndr. 2009 Jan 1;50(1):84-92. doi: 10.1097/QAI.0b013e31818d5a40.